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IL-4 is aT cell product originally described as B cell growth factor by virtue of
its ability to co-stimulate B lymphocyte proliferation (1) . It has broad effects on B
cells, including the promotion of Ig class switching toIgE andIgGl isotypes in acti-
vated B cells (2-7). In addition to regulating B lymphocyte growth and differentia-
tion, IL-4 modulates the survival, proliferation, and differentiation of T lympho-
cytes, as well as a wide range of hematopoietic cell lineages, thereby contributing
to allergic and other immune processes (8-10) . It has recently been reported that
murine IL-4 also exhibits antitumor effects in vivo (11) . IL-4 mediates its effects through
cell surface receptors ; a single class of high affinity receptors for IL-4 has been de-
tected on nearly all hematopoietic cells examined (12-17), and on many non-
hematopoietic cell types as well . These include human fibroblasts, epithelial cells,
and hepatic, bladder, and pancreatic tumor lines (13), as well as murine fibroblast,
muscle, neuroblast, epithelial, and a variety of stromal cell lines (12, 16). The biolog-
ical effect of IL-4 on most of these cells is unknown, but it has been reported that
IL-4 can stimulate fibroblast proliferation, andas such may play arole in inflamma-
tion (18) .
We recently reported theisolationand characterization ofamurine IL-4 receptor
(IL-4-R) cDNA (19), but themechanism(s) bywhichIL-4-R mediatethe pleiotropic
effects of IL-4 remains largely unknown . In this report we describe the cloning of
a human IL-4-R cDNA . The predicted amino acid sequence shows homology with
four other recently cloned receptors, and thus defines anovel receptor superfamily .
When transfected into a murine T cell line, the human IL-4-R cDNA confers re-
sponsiveness tohumanIL-4,demonstrating that theencoded protein contains sufficient
information to transmit the IL-4 signal across the cell membrane . This expression
system may prove useful foridentifyingcomponents of the IL-4 signal transduction
machinery.
Materials and Methods
Cells and Culture Conditions.
￿
Human peripheral bloodT cells (PBT)' were purified from
Address correspondence to Dr.M. Patricia Beckmann, Immunex Corp ., 51 University Street, Seattle,
WA 98101.
' Abbreviation used in this paper . PBT, peripheral blood T cells.
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three donors as described (20), and cultured in 1 Fig/ml PHA-P (Sigma Chemical Co., St.
Louis, MO) for 44 h before RNA isolation. COS-7 cells were maintained in DMEM with
10% FCS and antibiotics. CTLL-2 cells were grown as described (21). CTLLT22-8 and CTLL-
neo lines were grown in the same medium with the addition of 2.0 mg/ml G418.
RNA Isolation and cDNA Library Construction and Screening.
￿
Pooled human PBLs were ob-
tained by standard Ficoll purification, and were cultured in IL-2 for 6 d followed by stimula-
tion with PMA and Con A for 8 h. Polyadenylated RNA was isolated and used to construct
an oligo(dT)-primed cDNA library in Xgt10 using a cDNA synthesis kit (Amersham Corp.,
Arlington Heights, IL). A hybridization probe was produced by synthesizing an unlabeled
RNA transcript of the entire murine IL-4 receptor cDNA insert from clone 7119-4 (19), fol-
lowed by synthesis of a 32P-labeled single-stranded cDNA with reverse transcriptase using
random primers (Boehringer Mannheim Biochemicals, Indianapolis, IN). Hybridization to
plaque filters was carried out in 50% formamide, 0.4 M NaCl, 10 mM Pipes, pH 6.4, 1 mM
EDTA, 0.2% SDS, 0.1 mg/ml salmon sperm DNA at 42°C, followed by washing in 2 x SSC,
0.2% SDS at 55°C . The T22-8 cDNA clone was isolated from a library similarly prepared
from T22 cell polyadenylated RNA (22, 23) and screened with a 32P-labeled random-primed
probe made from clone PBL-1 .
Subcloning DNA Sequencing and RNA Blot Hybridization.
￿
These methods were carried out
as previously described (19). RNA blot hybridization used antisense riboprobesderived from
human IL-4-R clone PBL-1 and murine IL-4-R clone 7139-2 (19) in 50% formamide, 5 x
SSC, 0.5o7o SDS, 5 x Denhardt's, 50 mM Na(H)P04, pH 7.0, 0.1 mg/ml salmon sperm DNA
at 63°C followed by washing at 68'C in 0.1 x SSC, 0.2% SDS.
Transfection, Metabolic Labeling and Affinity Purification.
￿
COS-7 cells were transfected (24)
with 5 hgof the mammalian expression vector pDC302 (19) or pDC302 containing the human
IL-4-R cDNA clone T22-8. 3 d after transfection, cells were metabolically labeled with 100
pCi of [ssS]methionine and cysteine (Trans 35S-label; ICN Biomedicals, Inc., Irvine, CA)
for 1 h at 37°C, and then lysed (19). Lysates were incubated with a slurry of IL-4 Affigel
as previously described for murine IL-4 receptor (19), except that recombinant human IL-4
synthesized in yeast (13) was coupled to the beadsinstead of recombinant murine IL-4. Incu-
bation with the beadswas with or without 10 NAg ofuncoupled human IL-4. IL-4 Affigel beads
were then washed (19), and eluted proteins were analyzed by SDS-PAGE under reducing
conditions. CTLL-2 cells were electroporated (25) with 1 Fcg pSV2neo (26) and 10 FZg of ei-
ther pDC302 control plasmid or pDC302 containing the human IL-4-R cDNA T22-8. Cells
were cultured as previously described (21), with the addition of 2.0 mg/ml of G418.
Binding Assays.
￿
Equilibrium binding studies were performed on CTLL-neo and CTLL-
T22-8. Murine and human ' 251-IL-4 were prepared as described (13, 16). Specific activities
of 1 x 10'6 cpm/mmol were routinely achieved for both preparations. Briefly, equilibrium
binding analysis was done by incubating 2 x 106 CTLL-neo or CTLLT22-8 cells with var-
ious concentrations of murine '251-IL-4 or human '251-IL-4 for 1 h at 37°C in binding
medium (RPMI medium containing 2.5% bovine serum albumin, 0.2% sodium azide, and
0.2 M Hepes, pH 7.4). Free and cell-bound '251-IL-4 were separated by the pthalate oil
method (16). Nonspecific binding of 1251-IL-4 was measured in the presence of 200-fold
molar excess unlabeled IL-4. Binding data were analyzed with RStI software (Bolt, Beranek
and Newman, Boston, MA).
Proliferation Assays.
￿
[3H]TdR incorporation studies were done by incubating 2 x 103
CTLL-neo or CTLLT22-8 cells in microtiter plates at 37'C in DMEM, 10% FCS, with
various concentrations of recombinant murine IL-4 (16) or recombinant human IL-4 (13).
In some experiments, cells were also cultured in the presence of various concentrations of
anti-murine IL-4-R antibody (Beckmann, M. P, K. A. Schooley, B. Gallis, T. Vanden Bos,
D. Friend, A. R. Alpert, R. Raunio, K. S. Prickett, P E. Baker, and L. S. Park, manuscript
submitted for publication.). After 20 h of culture, cells were pulsed with 1 tuCi [3H]TdR
(Amersham Corp., Arlington Heights, IL) for 4 h. Cells were harvested onto glass strips and
[3H]TdR incorporation was determined on a Packard Tricarb 460 liquid scintillation counter.
Results shown are duplicate, independent experiments.IDZERDA ET AL.
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Results
Characterization ofHuman IL-4 Receptor cDNA Clones.
￿
A probe from the murine
IL-4 receptor cDNA clone 7B9-4(19) wasused to isolatehuman IL-4-R cDNA clones
from two libraries, one derived from human PBL, and the second from a CD4''/
CD8- human T cell line, T22 (22, 23). A restriction map and two representative
clones are diagrammed in Fig. 1 A. A full-length 3.6-kb cDNA clone, T22-8, con-
tains an open reading frame encoding 825 amino acids flanked by 175 by of 5' and
947 by of 3' noncodingsequence (shown in Fig. 1 B). The predictedproteinsequence
exhibits 53% identity with the murine IL-4 receptor, and contains a predicted 25
amino acid signal peptide, 207 amino acid external domain, 24 amino acid trans-
membrane region, and 569 amino acid cytoplasmic domain. Three of six potential
N-linked glycosylationsitesare conservedbetween thehuman and murine sequences.
Five of the seven cysteines present in the human IL-4-R extracellular domain are
also found in themurine IL-4-R. These presumably contribute to protein structure,
andtake on addedsignificance in view oftheirconservation in otherrelated receptor
sequences (see below).
The PBL-1 cDNA showed identical sequence to T22-8 except for a 68-bp inser-
tion that terminates the open reading frame 45 amino acids downstream of the
predicted NH2 terminus of the mature protein. This insertion was found in other
cDNA clones and therefore is not a cloning artifact but could represent unspliced
intronic sequences.
IL-4 Receptor IsA Member ofa New Superfamily.
￿
A search against the EMBL and
Genbank DNA and National Biomedical Research Foundation protein databases
(28) revealed that thehuman IL-4-R sequence is unique, as was foundwith the mu-
rine IL-4-R (19). However, in comparing the predicted amino acid sequence of the
IL-4-R with the published sequences of several recently cloned receptors, statisti-
cally significant homology was found among the extracellular domains. These se-
quences are the human IL-6-R (29), the human IL-2-R ,8 subunit (p75; reference
30), the murine erythropoietin receptor (31), and the rat prolactin receptor (32).
Like the IL-4-R, these receptor sequences are unique in the databases, and do not
contain tyrosine kinase domains or features that would classify them as members
of other gene super¬amilies (except IL-6-R, see below). Pairwise alignments of the
predicted extracellular domains of the receptors were performed with the ALIGN
program (33, 34), generating scores rangingfrom 3.9 to 8.8 (given in Table1). Scores
>3.0 are statistically significant and indicate common ancestry.
Shown in Fig. 2 is an alignment of the extracellular domains of these receptor
superfamilymembers. Invariant amino acids are designated in bold print, although
many more amino acids are conserved among the sequences. Distinguishing fea-
tures of the extracellular domains include four conserved cysteines and a COOH-
terminal double tryptophan-serine motif (WSXWS; see asterisks).
Expression ofHuman IL-4-R cDNA.
￿
Proofthat cDNA clone T22-8 encodes a bio-
logically active human IL-4-R was provided by biochemical andfunctional analyses
of the encoded protein in mammalian expression systems. COS-7 cells were tran-
sientlytransfected with the mammalian expression vector pDC302 (19), or pDC302
containing cDNA clone T22-8, and were metabolically labeled with [35S]methio-864 MOLECULAR CLONING OF THE HUMAN INTERLEUKIN 4 RECEPTOR
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Each receptor was compared using the ALIGN program, which computes the
optimal alignment of two sequences andgenerates an alignment score (33, 34).
A score > 3 .0 SD is statistically significant. Amino acids 1-207 of the human
IL-4-R (ML-4-R; Fig. 1 B), 1-208 of murine IL-4-R (mIL-4-R; reference 19),
106-329 of human IL-6-R (hIL-6-R; reference 29), 1-214 of human IL-2-RQ
subunit (ML-2-RS; reference 30), 37-249 of murine erythropoietin receptor
(mEPO-R; reference 31), and 20-229 of rat prolactin receptor (rPRL-R; refer-
ence 32) were compared.
nine and [31S]cysteine. Radiolabeled receptors were purified from cell lysates by
affinity chromatography on human IL-4 coupled to Affigel, and subjected to SDS
polyacrylamide gel electrophoresis. As shown in Fig. 3A, amajorIL-4 bindingpro-
teinof 140 kDwasproduced incells transfected with theT22-8 expression construct
(lane 3) but not in cells transfected with vector DNA (lane 1). Addition ofexcess
human IL-4 to the affinity purification (lanes 2 and 4) blocked the reactivity ofthe
IL-4 Afflgel with the expressed IL-4-R protein (lane 4). This size correlates well
with the observedMr (139,000) ofthe native human IL-4 receptor on both gingival
fibroblasts and the Raji B cell line (13). Similarly, the recently isolated full length
murine IL-4 receptor cDNA encodesa 139kD protein intransfected COS-7 cells(19).
Human IL-4-R cDNA Confers Human IL-4 Responsiveness to Murine CTLL-2 Cells.
￿
We
next sought to determine whether the cloned human IL-4-R could mediate a bio-
logical response to IL-4. The cloned murine Tcell line, CTLL-2 (35), typically ex-
hibits 1,000-4,000 IL-4-Rs per cell (16) and shows short-term proliferation in re-
sponse to murine IL-4 (10). Because murine and human IL-4 are species-specific
with respect to receptor binding (13-16), CTLL-2 cells do not bind or respond to
human IL-4. Thus, this cell line provides an ideal host for examining biological ac-
tivity ofthe cloned human IL-4-R cDNA. A stable cell population (CTLLT22-8)
expressing the human IL-4-R was derived by cotransfection ofCTLL-2 cells with
the pDC302/T22-8 expression construct and the plasmid pSV2neo (which encodes
resistance to neomycin; reference 26), followed by selection for growth in the pres-
ence of the antibiotic G418. A control line (CTLL-neo) was established by co-
transfection ofCTLL-2 cells withpDC302 vector and pSV2neo plasmid DNAs, fol-
lowed by selection in G418.
FIGURE 1.
￿
HumanIL-4-R cDNAs. (A) cDNA clones T22-8 and PBL-1 are diagrammed along
with a restriction map. Bar denotes coding region. Location of 68-bp insertion in clone PBL-1
is shown (0). (B) Nucleotide andpredicted amino acid sequence ofclone T22-8. Thepredicted
signal peptide and transmembrane region are marked by light and heavy underlining, respec-
tively. Potential N-linked glycosylation sites and extracellular cysteines have asterisks andboxes,
respectively. The dotted line marks the putative polyadenylation signal.
Alignment Scores
hIL-4-R
TABLE
of the
mIL-4-R
I
Predicted Extracellular
hIL-6-R
Domains
hIL-2-R13
mIL-4-R 30.4
hIL-6-R 6.5 6.3
hIL-2-RO 6.1 4.7 4.8
mEPO-R 6.7 4.8 8 .1 7.7
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huIL-4R
￿
MKVL-----QEP---TCVSDY-MSISTCENKMNGPTNCSTELRLLYQLVFL-LSEAH
muIL-4R
￿
IKVL-----GEP---TCFSDY-IRTSTCENFLDSAVDCSSQLCLHYRLMFFEFSENL
huIL-2V
￿
AVN-----GTSQF-TCFYNS-RANISCVWSQDGALQ-DTSCQVHAWPDR--RRWNQ
hUIL-6R VHLLVDVPPEEPQL-SCFRKSPLSNVVCENGPRSTPSLTTKAVLLVRKFQ--NSPAE
MURPOR SKAALLASRGSEELL-CFTQR-LEDLVCFWEEAASSGMDFNYSFSYQLEGE--SRK-
raPRLR QSPPGKPEIHKCRSPD-KETFTCWWVPGTDGGLPTNYSLTYSKEGE-KTTYE
----TCIPENNGGAGCV----CHLLMDDVVSADNYTLD---L----WAGQ--QLLWKGSFKPSEHVKP
----TCIPRNSASTVCV----CHMEMNRPVQSDRYQME---L----WAEH--RQLWQGSFSPSGNVKP
----TCELLPVSQASWA----CNLILGAPDSQKLTTVDIVTLRVLCREGVRWRVMAIQDFKPFENLRL
DFQEPC-QYSQESQKFS----CQLAVPEGDSS-FYIVS---MCVASSVGS--KFSKTQTFQGCGILQP
----SCSLHQAPTVRGSVRFWCSL--PTADTSSFVPLE---LQVTEASGS---PRYHRIIHINEVVLL
-----C-PDYKTSGPNS----CFFSKQYTSIWKIYIIT---VNATNQMGS--SSSDPLYVDVTYIVEP
RAPGNL--TVHTNVSD-TLL-LTWSNPYPPD-NYLYNHLTYAVNIWSENDPADFRIYNVTYLEPSLRI
LAPDNL--TLHTNVSD-EWL-LTNNNLYPSN-NLLYKDLISMVNISREDNPAEFIVYNVTYKEPRLSF
MAPISL----QVVHVETHRCNISN-EISQAS-HYFERHLEFEARTLSPGHTWEEAPL-LTLKQKQEWI
DPPANIT--VTAVARNPRWLSVTWQDPHSWN--SSFYRLRFELRYRA-ERSKTFTT--WMVKDLQHHC
DAPAGL---LARRAEEGSHVVLRNLPPPGAPMTT---HIRYEVDVSAGNRAGGTQR--VEVLEGRTEC
EPPRNLTLEVKQLKDKKTYLWVKNSPPTITDVKTGWFTMEYEIRLKP-EEAEEWEI---HFTGHQTQF
AASTLKSGISYRARVRAW-A-QCYNTTWSENS-P---STKWHNSYREPFEQH
PINILMSGVYYTARVRVR-S-QILTGTWSEWS-P---SITWYNHFQLPLIQR
CLETLTPDTQYEFQVRVK-PLQGEFTTWSPNSQP------- LAFRTKPAALGKDT
VIHDAWSGLRHVVQLRAQ--EEFGQGENSEWS-PEAMGTPWTESRSPPAENEVST
VLSNLRGGTRYTFAVRARMAEPSFSGFWSAMSEP---ASLLTASDLDP
KVFDLYPGQKYLVQTRCK-PD---HGYNSRWSQES-------- SVEMPNDFTLKD
FIGURE 2 .
￿
Sequence alignmentofextracellulardomains. Amino acidsconservedamongallfive
receptorsareshownin bold print. Alignmentofthe sequencesspecifiedin Table I wasperformed
by computer using the algorithm of Feng and Doolittle(45), and then modified to more closely
reflect the pairwise alignments produced by theALIGN program. The alignment shown is not
necessarily optimal for each individual pair of receptors.
Expression of murine and human IL-4-Rs in these lines was first examined by
radiolabeled-IL-4 binding and Scatchard analysis. Representative binding studies
(Fig. 3 B) indicate that both CTLL-neo cells (toppaneo as well as CTLLT22-8 cells
(middlepaneo have -1,400 murine IL-4-Rs on thecell surface with an affinity ofti4 x
109/M. As expected, no apparent human 1251-IL-4 binding was detected on the
CTLL-neo cells (not shown). However, >800 human IL-4-Rs could be detected on
the transfected CTLLT22-8 cells (Fig. 3 B, bottom paneo with an affinity forhuman
IL-4 of 1.1 x 101°/M. These binding affinities are consistent with the values previ-
ously reported for the native murine (12, 14-16) and human (13, 17) IL-4-Rs.
Expression ofmurine and human IL-4-R mRNA was examined inthe transfected
lines byRNAgelblotanalysis. A blot containingRNAfrom CTLLT22-8and CTLL-
neo cells, and for comparison human peripheral blood Tlymphocytes, was hybrid-
ized under stringent conditions with a human IL-4-R probe (Fig. 4 A). Shown in
Fig. 4 B is a blot containing CTLLT22-8 and CTLL-neo RNAs that was hybrid-
ized with a probe specific for murine IL-4-R mRNA. The murine probe detected
only the endogenous 3.9-kbmurine IL-4-R mRNA, which was expressed at similar
levels in the two CTLL sublines. The human IL-4-R probe hybridized to a 4.0-kb
endogenous IL-4-R mRNA in the human T cells, but did not detect the murine
form in the CTLL-neo control line. In the CTLLT22-8 transfectants the humanIDZERDA ET AL.
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FIGURE 3 .
￿
(A) Detection of thehumanIL-4-R expression product in transfectedCOS-7 cells.
Radiolabeled lysates from COS-7 cells transfected with pDC302 vectorDNA (vector lanes) or
the pDC302T22-8 expression construct (T22-8 lanes) were incubated with humanIL-4 Affigel
in the presence (+) or absence (-) of an excess of human IL-4, and the bound proteins were
subjected to electrophoresis and autoradiography. The mobilities of molecular weight standards
are indicated . (B) IL-4 bindingcharacteristicsoftransfectedCTLL-2 cells . Forequilibrium binding
studiesCTLL-neo (top) orCTLLT22-8 (middleand bottom) cells were incubatedwith various con-
centrations of murine 1251-IL-4 (top and middle) or human 125ML-4 (bottom) for 1 h as previ-
ously described (13). Nonspecific binding of 1251-11-4 wasmeasured in the presence of 200-fold
molar excess of unlabeled IL-4. Binding data were analyzed with RS/l software (Bolt, Beranek
and Newman, Boston, MA) .
probe hybridized toa 4.3-kbmRNA, consistent with the predicted size ofthe exoge-
nous humanIL-4-R mRNA, whichshould contain an additional 0.25 kb of 5' flanking
sequences transcribed from the expression vector. Surprisingly, a 3.0-kbRNA spe-
cies is also evident in the CTLLT22-8 lane . This could result from any of several
events such as aberrant splicing, gene rearrangement during integration into the868 MOLECULAR CLONING OF THE HUMAN INTERLEUKIN 4 RECEPTOR
FIGURE 4.
￿
Expression ofhuman IL-
4-R mRNA in transfected CTLL-2
cells . RNA gel blots containing 8 Wg
per lane total RNA from human pe-
ripheral bloodT cellsthathadbeen cul-
tured for 44 h in 1 Wg/ml ofPHA(PBT,
A), CTLL-T22-8 umsformants (CTLL-
T22-8,Aand B),andCTLL-neo trans-
formants (CTLL-neo, A andB) were
probed for (A)humanand(B) murine
IL-4-RmRNA . The positions of 28S
and 18S ribosomalRNAs are marked.
genome, or utilization of a cryptic polyadenylation signal within the cDNA . The
sequenceAGTAAA, which occurs at position 2540 (Fig . 1 B) might function as such
a signal, although there is no evidence for its use in normal human cells .
The ability of theexpressedhuman IL-4-Rs in CTLLT22-8 cells to convey a bio-
logical signal across the membrane was assessed by quantifying the proliferative re-
sponse of these cells to human IL-4 . The results, comparing [3H]thymidine incor-
poration in response to various concentrations ofhuman and murine IL-4 in the
twoCTLL sublines, are shown in Fig. 5A. While theCTLL-neo control line prolifer-
ated only in the presence of murine IL-4, the CTLLT22-8 cells responded to both
murine andhuman IL-4 . Moreover, addition of anti-murine IL-4-R mAb (Ml),
which blocks murine IL-4 binding(Beckmann,M. P, et al ., manuscript submitted
for publication), abrogated the response to murine IL-4 in the CTLLT22-8 cell
line, while having no effect on the biological response to human IL-4 (Fig . 5 B) .
Similarly, the anti-murine IL-4-R antibody blockedthe proliferative activity ofmurine
IL-4 on theCTLL-neo cells (data not shown) . Thesedata demonstrate that the prolifer-
ative response ofCTLLT22-8 cells to humanIL-4 wasmediated through thehuman
IL-4-R encoded by cDNA clone T22-8 .
Discussion
We have isolated cDNA clones that hybridize with a murine IL-4 receptor probe .
The protein sequence encoded by these clones matches closely with that determined
for the murine IL-4-R (19), and its identity as the human IL-4-R is confirmed by
functional expression of the cDNA in COS-7 and CTLL-2 cells. In murine cellsA
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(A)Proliferativeresponsiveness oftransfected CTLL-neo andCTLLT22-8 cells (A
and B, respectively) to recombinant murine IL-4 (O)or recombinant humanIL-4 (0). (B)Mito-
genic responsiveness ofCTLLT22-8 in the presence of anti-human IL-4-R antibody. CTLL-
T22-8 cells were stimulated with 0.5 ng/ml of murine (O) or human (") IL-4 in the presence
ofvarious concentrations of anti-murine IL-4-R antibody (1-140 ng/ml; reference27). Anti-mu-
rine IL-4-R antibody alone (0) was used as a control.
we found an alternativelyspliced mRNA that encoded a secreted form ofthe IL-4-R
(19), but an analogous cDNA has not yet been isolated in the human system. How-
ever, if a secreted form of the human IL-4 receptor is expressed at the same low
frequency as the murine secreted form (N1 in 15 cDNAs), then a large number of
human IL-4-R cDNAs would have to be examined to rule out itsoccurrence. Alter-
natively, expression of secreted IL-4-Rs may be restricted to the murine species.
The sequence comparisons shown in Table I and Fig. 2 define the IL-4-R as a
member of a novel superfamily of cytokine receptors. The ALIGN scores are in a
range similarto that found amongthe membersof the Ig gene superfamily. Because
all ofthese receptors can be found on, andmediateeffects on, cellsof thehematopoi-
etic lineage, we suggest thename, hematopoietin receptor superfamily. As additional
members of this family are discovered and as receptor structures are examined, the
significance ofthe conserved residues highlightedin Fig. 2 maybecome more evident.
It is interesting to note that these apparently structurally related receptors bind
moleculesthat also share similar structures. The x-raycrystallographic data of IL-2
showsthat it hasafour-helix bundle core structure (36). IL-6 has also been modeled
as a helix bundle protein (37). Although the structure of prolactin is not known,
x-ray crystallographic data on the closely related protein, growth hormone, reveal
that it has afour-helix bundle structure (38). Therefore, conservation ofthe binding
region in this family of receptors may be due to the structural requirements neces-
sary to bind aspecific class of hormones, and would predict that erythropoietin and
IL-4 may also have four-helix bundle structures.
Interestingly, the first 86 amino acids of the mature IL-6-R extracellular domain
are unrelated in sequence to thehematopoietin receptor superfamily as determined
with the UWGCG GAP program (28), which uses the same algorithm as ALIGN,870 MOLECULAR CLONING OF THE HUMAN INTERLEUKIN 4 RECEPTOR
but has a gap length penalty and no end gap penalty. However, the NH2-terminal
81 amino acids ofthe mature IL-6-R alignwith the Ig superfamilyC2 domain (29,
39), indicating that the extracellular portion of the IL-6-R has an NH2-terminal
Ig-like domain, followed by a domain characteristic of the hematopoietin receptor
superfamily. Whether IL-6 binding and biological responsiveness require both do-
mains is not yet known.
Thedemonstration ofsignal transduction by the human IL-4-R in murine CTLL-2
cells in response to human IL-4 indicates that homology between the murine and
human IL-4 receptor must be sufficient to allow interaction of the human IL-4-R
with the murine proteins involved in transmitting the IL-4 signal to the nucleus.
Presumably, thecytoplasmicdomain functions in this capacity. The amino acid se-
quence identity between the predicted cytoplasmic domains of the human and mu-
rine IL-4-Rs is 54%, with the greatest conservation focused in two regions: amino
acids 232-259 and 685-727 (Fig. 1 B). Additional evidence suggesting the impor-
tance of the cytoplamic domain comes from previous experiments with CTLL-2
cells. CTLL-2 cell line derivatives that express a high number of endogenous mu-
rine IL-4-Rs with a truncated cytoplasmic domain no longer respond to murine
IL-4 (19). This is in contrast to the IL-6 receptor, whose 86 amino acid cytoplasmic
domain is dispensable for signal transduction (40).
Examination ofthe predicted cytoplasmicdomain sequence ofthe human IL-4-R
revealed no clues about the signaling mechanism. No homologies with protein ki-
nases or sequences found at phosphorylation acceptor sites for protein tyrosine ki-
nases or protein kinase C (41, 42) were observed.
No significant homologies between thepredicted cytoplasmic domains of the IL-
4-Rs and the other members of thehematopoietin receptor superfamily, whichvary
greatly in length, were observed using the ALIGN program. D'Andrea et al. (43)
recently reported homology between the entire length oftheß subunit ofthe IL-2-R
and the erythropoietin receptor, which are roughly equivalent in size. In view of
the similarities between IL-4-R and these other receptors, it will be interesting to
determinewhethercomponents ofthe signalingmachinery areshared amongthem.
In addition, analysis of the genomic structure of these receptor genes might shed
further light not only on their evolutionary relatedness, but on domain structural
and functional similarities as well.
During the preparation of this paper, we became aware that Bazan (44) had also
noticed the sequence similarities between the receptors described here (with the ex-
ception of IL-4-R).
Summary
IL-4, a pleiotropic cytokine produced by Tlymphocytes, plays an important role
in immune responsiveness by regulating proliferation and differentiation of a va-
riety of lymphoid and myeloid cells via binding to high affinity receptors. In this
report we describe theisolation and functional expression of ahumanIL-4-R cDNA.
When transfected into COS-7 cells, the cDNA encodes a 140-kD cell-surface pro-
tein. After transfection into a murine T cell line, the cDNA encodes a protein that
binds human IL-4 with high affinity and can confer responsiveness to human IL-4.
The predicted extracellular domain of the IL-4-R exhibits significant amino acidsequence homology with the S subunit of the IL-2-R (p75), and the receptors for
IL-6, erythropoietin, and prolactin. These receptors comprise a novel superfamily
with extracellular domains characterized by four conserved cysteine residues and
a double tryptophan-serine (WSXWS) motif located proximal to the transmembrane
region.
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software; S. Lupton for assistance with electroporation; W. Fanslow for helpful discussions;
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